MMP1 and respiratory system disorder: In terms of translational medical implications, our findings suggest the potential for topical delivery of compounds to human airways that can down-regulate RAS-induced MAP kinase signaling, culminating in the activation of MMP-1, which might be of benefit for patients at risk of developing ultimately devastating respiratory diseases linked to MMP-1 dysregulation (Mercer and D’Armiento 2006).